After 1 Year as Interim COO, Exec Is Named COO of Spectral AI

Dallas-based Spectral AI said that since taking on the interim role in 2024, Stanley Micek has overseen the data science, software, hardware, imaging, and systems teams working directly on the company's FDA submission.

Interim chief operating officer Stanley Micek has been named chief operating officer of Spectral AI, a Dallas-based artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care.

Micek served as interim COO since May 2024.

“Stan has demonstrated exceptional leadership, operational insight, and a deep understanding of our business during his time as interim COO,” Dr. J. Michael DiMaio, M.D., chairman of the company’s board of directors, said in a statement. “His efforts leading our research and development group and his ability to drive performance, foster cross-functional collaboration, and execute on strategic priorities made it clear that he was the right person to lead our operations moving forward.”

Spectral AI said that since taking on the interim role, Micek has overseen the data science, software, hardware, imaging, and systems teams working directly on the company’s FDA submission.

Before becoming interim COO, Micek was the senior vice president for business development & strategy at MiMedx and held numerous leadership roles at Ohio State University at the Ohio State Comprehensive Cancer Center, bringing over 25 years of leadership experience in healthcare and acute wound expertise.

“I’m honored to continue this journey with Spectral AI and excited to lead our operations team as we build on our momentum from our recent Pivotal Burn Study,” Micek said in a statement. “Together, we’ll strive for excellence in providing a ground-breaking wound diagnostic tool and I am excited to work to drive our submission to the FDA in the near future.”


Don’t miss what’s next. Subscribe to Dallas Innovates.

Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.

One quick signup, and you’re done.

 

R E A D   N E X T